Breakthrough Approval: Fengkaili Medical's SynFlow® 3.0 Redefines Cost Efficiency in Mechanical Circulatory Support, Marking a 'SpaceX Moment' for Interventional Pumps

[Image] On June 18, ForQaly’s independently developed SynFlow® 3.0 percutaneous transvalvular ventricular assist system received market approval from the National Medical Products Administration (NMPA). The system comprises a blood pump catheter, an external control unit, perfusion tubing, and a catheter sheath kit. It is indicated for high-risk percutaneous coronary intervention (PCI) in patients with severe coronary artery disease, reduced left ventricular ejection fraction, and hemodynamic...